PMID: 99 Iglesias-MatesanzPLacalle-GonzalezCLopez-BlazquezCOchieng' OtienoMGarcia-FoncillasJMartinez-UserosJ
Compounded Semaglutide The gold standard in GLP-1 weight management Compounded Tirzepatide Dual-action GIP/GLP-1 for maximum results Liraglutide The proven GLP-1 pioneer with years of clinical data BPC-157 15mg vial The body protection compound for accelerated healing BPC-157 / TB-500 Blend 5mL vial The ultimate recovery stack in one vial Sermorelin 15mg vial Bioidentical GHRH analog for natural growth hormone pulsatility PT-141 (Bremelanotide) Injectable vial FDA-approved for women with low sexual desire
Caloric restriction is not ideal during recovery because your body will need copious amounts of energy to heal and repair tissues and rid itself of waste products
At Studio Medical Aesthetics in Georgetown, KY, we combine advanced aesthetic medicine with a personalized, patient-first approach to help you look refreshed and feel confident
Eli Lilly, Novo Nordisk expand operations amid GLP-1 drug boom Biopharma bigwigs Eli Lilly and Novo Nordisk are upping capacity to meet the rising demands of GLP-1 drugs
The FLOW trial (Perkovic et al, NEJM 2024) was a phase 3 randomized trial, of 3,533 patients with type 2 diabetes and CKD (eGFR 50-75ml/min or 25-50 ml/min with albuminuria) who received 1 mg of subcutaneous semaglutide weekly, or placebo